Freestone Grove Partners’s Ardelyx ARDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.29M Sell
253,692
-1,626,091
-87% -$9.93M 0.01% 498
2026
Q1
$11.3M Buy
1,879,783
+1,180,650
+169% +$7.81M 0.08% 271
2025
Q4
$4.08M Buy
699,133
+297,378
+74% +$1.66M 0.03% 364
2025
Q3
$2.21M Buy
401,755
+244,364
+155% +$1.33M 0.02% 365
2025
Q2
$617K Buy
157,391
+141,330
+880% +$583K ﹤0.01% 498
2025
Q1
$78.9K Sell
16,061
-270
-2% -$1.45K ﹤0.01% 564
2024
Q4
$82.8K Buy
+16,331
New +$90.2K ﹤0.01% 563

Other funds holding ARDX

Freestone Grove Partners's ARDX Position: Q2 2026 in Review

Freestone Grove Partners reduced its Ardelyx (ARDX) stake by 87% in Q2 2026, selling an estimated $9.93M and leaving 253,692 shares worth $1.29M. The position accounts for 0.01% of the portfolio, ranked #498.

Freestone Grove Partners first reported a position in ARDX in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.3M in Q1 2026. 249 funds tracked by Wall St. Rank hold ARDX as of Q2 2026.

  • Freestone Grove Partners held 253,692 shares of Ardelyx worth $1.29M as of Q2 2026.
  • Freestone Grove Partners sold 1,626,091 Ardelyx shares in Q2 2026, an estimated $9.93M.
  • Ardelyx made up 0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #498 holding.
  • Freestone Grove Partners first reported a position in Ardelyx in Q4 2024 and has held it in 7 quarters since.
  • Freestone Grove Partners's Ardelyx position peaked at $11.3M in Q1 2026.
  • 249 funds tracked by Wall St. Rank held Ardelyx as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.